The latest closing stock price for Cadrenal Therapeutics as of November 20, 2024 is 14.50.
An investor who bought $1,000 worth of Cadrenal Therapeutics stock at the IPO in 2023 would have $2,519 today, roughly 3 times their original investment - a 87.60% compound annual growth rate over 2 years.
The all-time high Cadrenal Therapeutics stock closing price was 17.89 on November 11, 2024.
The Cadrenal Therapeutics 52-week high stock price is 19.97, which is 37.7% above the current share price.
The Cadrenal Therapeutics 52-week low stock price is 0.36, which is 97.5% below the current share price.
The average Cadrenal Therapeutics stock price for the last 52 weeks is 3.77.
An investor who bought $1,000 worth of Cadrenal Therapeutics stock at the IPO in 2023 would have $2,519 today, roughly 3 times their original investment - a 87.60% compound annual growth rate over 2 years.
The all-time high Cadrenal Therapeutics stock closing price was 17.89 on November 11, 2024.
The Cadrenal Therapeutics 52-week high stock price is 19.97, which is 37.7% above the current share price.
The Cadrenal Therapeutics 52-week low stock price is 0.36, which is 97.5% below the current share price.
The average Cadrenal Therapeutics stock price for the last 52 weeks is 3.77.